P53 Antibody

<strong>p53 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015950_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> p53 Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hsiue EH, Wright KM, Douglass J, Hwang MS, Mog BJ, Pearlman AH, Paul S, DiNapoli SR, Konig MF, Wang Q, Schaefer A, Miller MS, Skora AD, Azurmendi PA, Murphy MB, Liu Q, Watson E, Li Y, Pardoll DM, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Gabelli SB, Zhou S. Targeting a neoantigen derived from a common TP53 mutation Science. 2021 Mar 5;371(6533):eabc8697._x000D_ 2: Hasbek Z, Turgut B, Erselcan T. p53 antibody: is it an indicator of dedifferentiated thyroid cancer? Ann Nucl Med. 2014 Jan;28(1):42-6._x000D_ 3: Wei YP, Zhang YW, Chen JS, Mao CJ, Jin BK. An electrochemiluminescence biosensor for p53 antibody based on Zn-MOF/GO nanocomposite and Ag(+)-DNA amplification Mikrochim Acta. 2020 Jul 18;187(8):455._x000D_ 4: Hirokawa S, Araki K, Yamashita T, Uno K, Tomifuji M, Shimada H, Shiotani A. The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma Acta Otolaryngol. 2023 Jan;143(1):85-90._x000D_ 5: Sobhani N, D'Angelo A, Wang X, Young KH, Generali D, Li Y. Mutant p53 as an Antigen in Cancer Immunotherapy Int J Mol Sci. 2020 Jun 8;21(11):4087._x000D_ 6: Thomas MG, Luchelli L, Pascual M, Gottifredi V, Boccaccio GL. A monoclonal antibody against p53 cross-reacts with processing bodies PLoS One. 2012;7(5):e36447._x000D_ 7: Chang Y, Liu B, Niu H, Wang Z, Xia S, Li H. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis Medicine (Baltimore). 2020 Aug 21;99(34):e21887._x000D_ 8: Low L, Goh A, Koh J, Lim S, Wang CI. Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen Nat Commun. 2019 Nov 26;10(1):5382._x000D_ 9: West HJ, McCleland M, Cappuzzo F, Reck M, Mok TS, Jotte RM, Nishio M, Kim E, Morris S, Zou W, Shames D, Das Thakur M, Shankar G, Socinski MA. Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial J Immunother Cancer. 2022 Feb;10(2):e003027._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/37640588">10: Kabrani E, Saha T, Di Virgilio M. DNA repair and antibody diversification: the 53BP1 paradigm Trends Immunol. 2023 Oct;44(10):782-791. </a>_x000D_ _x000D_ <strong>Products Related to p53 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>